TARIS Biomedical
Lexington
About TARIS Biomedical
TARIS Biomedical develops new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's system is designed to continuously release drugs in the bladder over weeks to months and is deployed and retrieved using minimally-invasive, in-office procedures, enabling drug release to be tailored to match the needs of each disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $113.1M
- Funding stage: M&A
- Last round: Series B (Dec 2017)
- Website: tarisbiomedical.com
- Phone: +1 781 676 7750
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/taris-biomedical-142638 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.